National Organization for Rare Disorders

New Von Willebrand Disease Clinical Trials Focused on Prophylactic Treatment and Pregnancy

Oct 7, 2019 | National Organization for Rare Disorders, Octapharma USA, Pregnancy, Von Willebrand Disease

Octapharma USA sponsored the National Hemophilia Foundation’s (NHF) 71st Bleeding Disorders Conference and introduced two new clinical trials focused on von Willebrand Disease (VWD). The clinical trials were featured in poster...

NORD Turns 30 Years Old: Announces Research Funding for Rare Disorder Basic Research

May 1, 2019 | National Organization for Rare Disorders, Rare Diseases

The National Organization for Rare Disorders® (NORD), the leading independent nonprofit organization representing the 25-30 million Americans living with rare diseases, is celebrating the 30th anniversary of its Rare Disease Research Grant Program by announcing the...

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

159 WEST BROADWAY SUITE 200
SALT LAKE CITY, UT 84101

New Von Willebrand Disease Clinical Trials Focused on Prophylactic Treatment and Pregnancy

NORD Turns 30 Years Old: Announces Research Funding for Rare Disorder Basic Research

Pin It on Pinterest